Detalhe da pesquisa
1.
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.
J Formos Med Assoc
; 120(3): 956-964, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077341
2.
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.
J Formos Med Assoc
; 117(6): 497-504, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28694000
3.
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
J Gastroenterol Hepatol
; 31(4): 835-41, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26478984
4.
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.
Gut
; 64(2): 303-11, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24747867
5.
The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.
J Gastroenterol Hepatol
; 30(12): 1768-74, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26094738
6.
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Hepatology
; 57(6): 2135-42, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23322699
7.
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection.
J Gastroenterol Hepatol
; 29(5): 1012-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24325201
8.
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
Ann Intern Med
; 159(11): 729-38, 2013 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297189
9.
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.
J Gastroenterol Hepatol
; 28(9): 1515-20, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23560893
10.
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients.
Hepatology
; 53(1): 7-13, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21254157
11.
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.
Liver Int
; 32(6): 962-9, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22356575
12.
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.
J Hepatol
; 54(2): 219-26, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21056500
13.
Pegylated interferon plus ribavirin therapy improves pancreatic ß-cell function in chronic hepatitis C patients.
Liver Int
; 31(8): 1155-62, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21745292
14.
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
J Gastroenterol Hepatol
; 26(3): 530-5, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21332548
15.
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.
J Infect Dis
; 201(5): 751-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20102281
16.
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
J Infect Dis
; 202(1): 86-92, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20482252
17.
Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa.
Expert Rev Gastroenterol Hepatol
; 15(4): 427-435, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338385
18.
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Gastroenterology
; 136(2): 496-504.e3, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19084016
19.
Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3.
Hepatology
; 60(6): 2129-30, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24591145
20.
A 24-week pegylated interferon alpha-2b versus a 12-week pegylated interferon alpha-2b alone or with ribavirin for patients with acute hepatitis C.
Hepatology
; 60(6): 2128-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24585417